It has been suggested that the defect in coagulation of blood in hemophilia resides in a globulin fraction of the plasma (1, 2). Globulin substance, prepared by isoelectric precipitation from citrated, cellular-free, normal human plasma, posseses marked clot-accelerating properties for hemophilic blood in vitro and in vivo. There is a prompt decrease in the blood coagulation time when a saline suspension of this material is injected either intravenously or intramuscularly into hemophilic subjects. The coagulation time remains low following such injections for approximately 6 hours, when it commences to return toward the pre-injection level. Attempts to maintain a reduction of the coagulation time with repeated injections of globulin substance led to the discovery that a refractory phase occurred after several injections had been given (2) . During this phase the coagulation time was little affected by repeated injections although it was demonstrated that the concentration of this clotaccelerating material progressively increased in the circulating blood of the patient. Recovery from this refractory state was always complete within 24 hours after the last injection of globulin substance. The present communication reports further studies concerning the refractory period and offers an explanation of certain aspects of this phenomenon.
METHODS
Coagulation time. The method by which the coagulation time of venous blood was determined has been described elsewhere (2) .
Control period. The investigation was carried out on four hemophilic patients between the ages of 18 and 48 years who had been under observation in this clinic for several years. The shortest blood coagulation time for these four patients was 40 minutes and the longest was 180 minutes. Prior to each set of observations a control period of 48 hours was established. If the coagulation time of the blood fluctuated appreciably during this period no test observations were made of that subject. Patients who had had recent hemorrhages were excluded from this study.
Preparation of globulin substance. The globulin substance was prepared from citrated normal human plasma in the same manner as previously described (2) . In all experiments the dried material was suspended in the same volume of 0.85 per cent sodium chloride solution as the volume of plasma from which it was derived, rendered sterile and free of particulate matter by Berkefeld filtration. Each lot of globulin substance, so prepared, was shown to have maximum clot-accelerating properties for hemophilic blood in vitro (2) before it was used parenterally.
Standard test dose. A standard test dose of 65 cc. of plasma or an equivalent amount of saline suspension of globulin substance was used for in vivo studies. The standard test dose of globulin substance contained approximately 300 mgm. of the dried material.
Preparation of dried material by the FlosdorfMudd technique. In certain instances, plasma or the freshly prepared, moist precipitate of globulin substance was dried by the lyophilic process as described by Flosdorf and Mudd (3) . This porous dry material prepared from either source was redissolved in an amount of distilled water equal in volume to that of the original plasma. 779
The effect of repeated intravenous injections of plasma. In view of the fact, shown by many observations, that a refractory phase followed repeated injections of globulin substance into hemophilic patients (Figure 1) , it was necessary to observe the effects of repeated injections of the parent plasma.2 Three hemophilic subjects were given a standard test dose of citrated normal human plasma intravenously, repeated four times at 6-hour intervals. The results obtained in one typical set of observations are presented in Figure 2. As shown in Figure 2 , the blood coagulation time was maintained near normal values, and throughout the entire period of observation there was no suggestion of the development of a refractory period following any injection of plasma.
The effect of dried plasma upon the coagulation time of hemophilic blood in vitro. Normal citrated human plasma was dried in open dishes at room temperature in a current of air created by an electric fan. The dry material, so obtained, was suspended in the same volume of distilled water as the original volume of the plasma, centrifuged, and then its clot-accelerating properties 2 All plasma referred to in this communication has been passed through a Berkefeld V filter. Figure 2 . The shortened coagulation time was maintained and a refractory period did not develop following any of the injections. The observations were repeated except that the plasma was administered intramuscularly. The results were again entirely similar.
The effect of drying globulin substance by the Flosdorf-Mudd technique. Globulin substance was prepared in the usual manner except that immediately after centrifugation the moist precipitate was frozen and dried under vacuum by the lyophilic process. This material was then ground, stored in a desiccator over calcium chloride, and as required suspended in the requisite amount of saline solution. The clot-accelerating properties of this preparation for hemophilic blood were tested in vitro (Table III) repeated four times at 6-hour intervals. The usual refractory period developed after the first two injections and the blood coagulation time gradually returned to the pre-injection level. The third and fourth injections were entirely without effect on the coagulation time of the blood. Immediately after the fourth injection and at the height of the refractory period when further injections of globulin substance have been shown to be ineffective (2) this subject received a standard test dose of lyophilized plasma intramuscularly. There was a sharp reduction in the blood coagulation time, and it appeared that the refractory phase had been abolished by this single injection of plasma (Figure 3 ).
COMMENT
The fact that many observations have shown that repeated injections of globulin substance into hemophilic patients produced a refractory phase, as indicated by failure of further injections of globulin substance to reduce the coagulation time of hemophilic blood (2) , necessitated further investigations to determine the nature of this reaction. Since the protein of the early preparations could have been denatured this condition might be considered a possible cause of the refractory phe- 
